Companies / Vir Biotechnology, Inc. / Activity
Activity — Vir Biotechnology, Inc.
44 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Sato Vicki L Director | Sell | Common Stock | $411.3K | -42K -3.55% | 1,144,591 0.68% of shares | medium |
| May 1, 2026 | Sato Vicki L Director | Sell | Common Stock | $221.0K | -22K -2.00% | 1,078,391 0.64% of shares | medium |
| Mar 2, 2026 | Sato Vicki L Director | Sell | Common Stock | $207.2K | -22K -1.90% | 1,122,591 0.66% of shares | medium |
| Apr 1, 2026 | Sato Vicki L Director | Sell | Common Stock | $199.6K | -22K -1.96% | 1,100,391 0.65% of shares | medium |
| Feb 2, 2026 | Sato Vicki L Director | Sell | Common Stock | $169.7K | -22K -1.89% | 1,144,391 0.68% of shares | medium |
| Feb 23, 2026 | De Backer Marianne CEO | Sell | Common Stock | $141.9K | -19K -1.81% | 1,035,466 0.61% of shares | medium |
| Feb 24, 2026 | De Backer Marianne CEO | Sell | Common Stock | $140.7K | -15K -1.43% | 1,020,704 0.60% of shares | medium |
| Feb 25, 2026 | de Verneuil Vanina Executive | Sell | Common Stock | $134.5K | -14K -10.81% | 112,982 0.07% of shares | medium |
| Jan 2, 2026 | Sato Vicki L Director | Sell | Common Stock | $130.4K | -22K -1.85% | 1,166,391 0.69% of shares | medium |
| Mar 23, 2026 | Sabatini Brent Executive | Sell | Common Stock | $70.3K | -8K -11.08% | 61,902 0.04% of shares | low |
| Feb 24, 2026 | Sato Vicki L Director | Exercise | Common Stock | $62.9K | +42K +3.70% | 1,186,768 0.70% of shares | low |
| Feb 23, 2026 | de Verneuil Vanina Executive | Sell | Common Stock | $33.1K | -4K -3.31% | 129,799 0.08% of shares | low |
| Feb 24, 2026 | de Verneuil Vanina Executive | Sell | Common Stock | $29.7K | -3K -2.40% | 126,682 0.07% of shares | low |
| Feb 25, 2026 | Eisner Mark Executive | Sell | Common Stock | $18.5K | -2K -1.21% | 154,024 0.09% of shares | low |
| Feb 24, 2026 | O'Byrne Jason Executive | Sell | Common Stock | $15.6K | -2K -0.99% | 162,615 0.10% of shares | low |
| Feb 23, 2026 | Eisner Mark Executive | Sell | Common Stock | $15.6K | -2K -1.31% | 157,529 0.09% of shares | low |
| Feb 23, 2026 | O'Byrne Jason Executive | Sell | Common Stock | $15.6K | -2K -1.26% | 164,249 0.10% of shares | low |
| Feb 24, 2026 | Eisner Mark Executive | Sell | Common Stock | $15.4K | -2K -1.03% | 155,913 0.09% of shares | low |
| Feb 24, 2026 | Sabatini Brent Executive | Sell | Common Stock | $13.6K | -1K -2.01% | 69,613 0.04% of shares | low |
| Feb 23, 2026 | Sabatini Brent Executive | Sell | Common Stock | $13.6K | -2K -2.51% | 71,043 0.04% of shares | low |
| Feb 13, 2026 | Sabatini Brent Executive | Sell | Common Stock | $11.9K | -2K -3.10% | 47,872 0.03% of shares | low |
| Feb 24, 2026 | Sato Vicki L Director | Sell | Common Stock | $2.1K | -200 -0.02% | 1,144,391 0.68% of shares | low |
| Mar 2, 2026 | Sato Vicki L Director | Sell | Common Stock | $2.0K | -200 -0.02% | 1,122,391 0.66% of shares | low |
| Jun 9, 2026 | Coughlin Timothy Director | Grant | Common Stock | $0 | +8K +100.00% | 16,000 <0.01% of shares | low |
| Jun 9, 2026 | Coughlin Timothy Director | Grant | Common Stock | $0 | +8K | 8,000 <0.01% of shares | low |
| May 27, 2026 | More Robert J Director | Grant | Common Stock | $0 | +8K +19.68% | 48,656 0.03% of shares | low |
| May 27, 2026 | Bischofberger Norbert W Director | Grant | Common Stock | $0 | +8K +60.00% | 21,333 0.01% of shares | low |
| Feb 22, 2026 | Eisner Mark Executive | Grant | Common Stock | $0 | +55K +52.57% | 159,618 0.09% of shares | low |
| Feb 22, 2026 | De Backer Marianne CEO | Grant | Common Stock | $0 | +285K +37.04% | 1,054,505 0.62% of shares | low |
| Mar 20, 2026 | O'Byrne Jason Executive | Other | Common Stock | $0 | +3K | 2,500 <0.01% of shares | low |
| Mar 20, 2026 | O'Byrne Jason Executive | Other | Common Stock | $0 | -3K -1.54% | 160,115 0.09% of shares | low |
| Feb 22, 2026 | Sabatini Brent Executive | Grant | Common Stock | $0 | +25K +52.22% | 72,872 0.04% of shares | low |
| Feb 22, 2026 | O'Byrne Jason Executive | Grant | Common Stock | $0 | +55K +49.40% | 166,338 0.10% of shares | low |
| Feb 22, 2026 | de Verneuil Vanina Executive | Grant | Common Stock | $0 | +55K +69.41% | 134,244 0.08% of shares | low |
| Jun 9, 2026 | Coughlin Timothy Director | Grant | Stock Option (Right to Buy) | — | +16K | 16,000 <0.01% of shares | low |
| Jun 9, 2026 | Coughlin Timothy Director | Grant | Stock Option (Right to Buy) | — | +16K | 16,000 <0.01% of shares | low |
| May 27, 2026 | More Robert J Director | Grant | Stock Option (Right to Buy) | — | +16K | 16,000 <0.01% of shares | low |
| May 27, 2026 | Bischofberger Norbert W Director | Grant | Stock Option (Right to Buy) | — | +16K | 16,000 <0.01% of shares | low |
| Feb 22, 2026 | Eisner Mark Executive | Grant | Stock Option (Right to Buy) | — | +110K | 110,000 0.07% of shares | low |
| Feb 22, 2026 | De Backer Marianne CEO | Grant | Stock Option (Right to Buy) | — | +570K | 570,000 0.34% of shares | low |
| Feb 24, 2026 | Sato Vicki L Director | Exercise | Stock Option (Right to Buy) | — | -42K -100.00% | 0 0.00% of shares | low |
| Feb 22, 2026 | Sabatini Brent Executive | Grant | Stock Option (Right to Buy) | — | +50K | 50,000 0.03% of shares | low |
| Feb 22, 2026 | O'Byrne Jason Executive | Grant | Stock Option (Right to Buy) | — | +110K | 110,000 0.07% of shares | low |
| Feb 22, 2026 | de Verneuil Vanina Executive | Grant | Stock Option (Right to Buy) | — | +110K | 110,000 0.07% of shares | low |